Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Convalescent plasma from COVID-19 donors
BIOLOGICAL
2 trials
Sponsors
Fundacion Arturo Lopez Perez
, Helsinki University Central Hospital
Conditions
COVID-19 Infection
Cancer Patients
Covid19
General Population
Phase 2
COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID)
NCT04384588
Fundacion Arturo Lopez Perez
Cancer Patients, COVID-19 Infection, General Population
Start: 2020-04-07
End: 2021-04-06
Target: 100
Updated: 2020-05-12
Convalescent Plasma in the Treatment of Covid-19
NCT04730401
Helsinki University Central Hospital
Covid19
Start: 2021-01-27
End: 2023-01-30
Target: 390
Updated: 2022-07-07
Related Papers
Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
Journal of Immunology Research
2021-02-19
7 citations
Convalescent Plasma in COVID-19; Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial
Journal of Vaccines & Vaccination
2021-01-01